SRTS vs. BARC.L

Last updated Jun 3, 2026

SRTS (Sensus Healthcare, Inc.) and BARC.L (Barclays plc) are both stocks. SRTS operates in Medical Devices (Healthcare), while BARC.L operates in Banks - Diversified (Financial Services). Over the past 5 years, SRTS returned -4.04%/yr vs 23.54%/yr for BARC.L. At a 0.11 correlation, their price movements are largely independent.

Performance

SRTS vs. BARC.L - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sensus Healthcare, Inc. (SRTS) and Barclays plc (BARC.L). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

SRTS is traded in USD, while BARC.L is traded in GBp. To make them comparable, the BARC.L values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, SRTS achieves a -28.64% return, which is significantly lower than BARC.L's 0.02% return.

SRTS

• 1D: -0.35%
• 1M: -28.64%
• YTD: -28.64%
• 6M: -30.05%
• 1Y: -39.83%
• 3Y*: 1.70%
• 5Y*: -4.04%
• 10Y*: —

BARC.L

• 1D: 3.47%
• 1M: 7.60%
• YTD: 0.02%
• 6M: 11.12%
• 1Y: 45.82%
• 3Y*: 53.12%
• 5Y*: 23.54%
• 10Y*: 12.69%

*Multi-year figures are annualized to reflect compound growth (CAGR)

SRTS vs. BARC.L - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
SRTS Sensus Healthcare, Inc.	-28.64%	-42.49%	193.22%	-68.19%	2.77%	87.05%	9.04%	-52.23%	43.60%	-1.71%
BARC.L Barclays plc	0.02%	95.96%	79.37%	7.11%	-21.50%	28.48%	-12.69%	29.82%	-28.50%	0.89%

Correlation

The correlation between SRTS and BARC.L is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.17
Correlation (3Y) Calculated over the trailing 3-year period	0.15
Correlation (5Y) Calculated over the trailing 5-year period	0.17
Correlation (All Time) Calculated using the full available price history since Jul 27, 2016	0.11

Fundamentals

Market Cap SRTS : $46.75M BARC.L : £64.54B
EPS SRTS : -$0.48 BARC.L : £0.52
PS Ratio SRTS : 2.06 BARC.L : 1.61
PB Ratio SRTS : 1.03 BARC.L : 0.84
Total Revenue (TTM) SRTS : $22.53M BARC.L : £40.71B
Gross Profit (TTM) SRTS : $8.51M BARC.L : £40.18B
EBITDA (TTM) SRTS : -$8.57M BARC.L : £9.83B

Return for Risk

SRTS vs. BARC.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SRTS

SRTS Risk / Return Rank: 16
SRTS Sharpe Ratio Rank: 18
SRTS Sortino Ratio Rank: 22
SRTS Omega Ratio Rank: 21
SRTS Calmar Ratio Rank: 10
SRTS Martin Ratio Rank: 9

BARC.L

BARC.L Risk / Return Rank: 77
BARC.L Sharpe Ratio Rank: 82
BARC.L Sortino Ratio Rank: 77
BARC.L Omega Ratio Rank: 75
BARC.L Calmar Ratio Rank: 73
BARC.L Martin Ratio Rank: 77

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SRTS vs. BARC.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sensus Healthcare, Inc. (SRTS) and Barclays plc (BARC.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SRTS	BARC.L	Difference
Sharpe ratio Return per unit of total volatility	-0.52	1.47	-1.99
Sortino ratio Return per unit of downside risk	-0.35	2.05	-2.39
Omega ratio Gain probability vs. loss probability	0.95	1.26	-0.31
Calmar ratio Return relative to maximum drawdown	-0.81	1.70	-2.51
Martin ratio Return relative to average drawdown	-1.33	4.97	-6.30
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SRTS vs. BARC.L - Sharpe Ratio Comparison

The current SRTS Sharpe Ratio is -0.52, which is lower than the BARC.L Sharpe Ratio of 1.47. The chart below compares the historical Sharpe Ratios of SRTS and BARC.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	SRTS	BARC.L	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.52	1.47	-1.99
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.05	0.70	-0.75
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.34	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.10	-0.01	-0.09

Drawdowns

SRTS vs. BARC.L - Drawdown Comparison

The maximum SRTS drawdown since its inception was -87.51%, smaller than the maximum BARC.L drawdown of -94.71%. Use the drawdown chart below to compare losses from any high point for SRTS and BARC.L.

Drawdown Indicators

	SRTS	BARC.L	Difference
Max Drawdown Largest peak-to-trough decline	-87.51%	-94.71%	+7.20%
Max Drawdown (1Y) Largest decline over 1 year	-49.73%	-26.54%	-23.19%
Max Drawdown (3Y) Largest decline over 3 years	-68.41%	-26.54%	-41.87%
Max Drawdown (5Y) Largest decline over 5 years	-87.51%	-47.53%	-39.98%
Max Drawdown (10Y) Largest decline over 10 years	—	-65.60%	—
Current Drawdown Current decline from peak	-81.03%	-17.73%	-63.30%
Average Drawdown Average peak-to-trough decline	-46.58%	-66.86%	+20.28%
Ulcer Index Depth and duration of drawdowns from previous peaks	30.32%	9.08%	+21.24%

Volatility

SRTS vs. BARC.L - Volatility Comparison

Sensus Healthcare, Inc. (SRTS) has a higher volatility of 33.13% compared to Barclays plc (BARC.L) at 11.16%. This indicates that SRTS's price experiences larger fluctuations and is considered to be riskier than BARC.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SRTS	BARC.L	Difference
Volatility (1M) Calculated over the trailing 1-month period	33.13%	11.16%	+21.97%
Volatility (6M) Calculated over the trailing 6-month period	52.54%	24.78%	+27.76%
Volatility (1Y) Calculated over the trailing 1-year period	76.19%	31.03%	+45.16%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	82.24%	33.69%	+48.55%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	73.58%	37.44%	+36.14%

Dividends

SRTS vs. BARC.L - Dividend Comparison

SRTS has not paid dividends to shareholders, while BARC.L's dividend yield for the trailing twelve months is around 1.83%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BARC.L Barclays plc	1.83%	1.79%	3.06%	5.01%	3.94%	1.60%	4.09%	3.90%	2.99%	1.48%	2.01%	2.97%
SRTS Sensus Healthcare, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both SRTS and BARC.L in my portfolio?

SRTS and BARC.L have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.